Media headlines about Hill-Rom Holdings (NYSE:HRC) have trended somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Hill-Rom Holdings earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave headlines about the medical technology company an impact score of 46.5310188585289 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
HRC has been the subject of a number of recent research reports. Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a research note on Monday, June 12th. ValuEngine raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Stifel Nicolaus boosted their price objective on shares of Hill-Rom Holdings from $70.00 to $84.00 and gave the company a “buy” rating in a research report on Monday, May 1st. Barclays PLC boosted their price objective on shares of Hill-Rom Holdings from $75.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, May 1st. Finally, Needham & Company LLC began coverage on shares of Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “buy” rating and a $95.00 price target for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $88.17.
Shares of Hill-Rom Holdings (HRC) traded down 1.27% during mid-day trading on Thursday, reaching $73.92. 264,561 shares of the company were exchanged. The stock has a 50 day moving average price of $78.85 and a 200-day moving average price of $73.18. Hill-Rom Holdings has a 12 month low of $50.50 and a 12 month high of $84.65. The stock has a market capitalization of $4.87 billion, a P/E ratio of 43.08 and a beta of 1.22.
Hill-Rom Holdings (NYSE:HRC) last issued its earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The business’s revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.81 EPS. Analysts predict that Hill-Rom Holdings will post $3.82 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be given a $0.18 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.72 annualized dividend and a dividend yield of 0.97%. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.
In related news, SVP Andreas G. Frank sold 10,660 shares of the business’s stock in a transaction dated Tuesday, June 6th. The shares were sold at an average price of $78.62, for a total value of $838,089.20. Following the completion of the transaction, the senior vice president now owns 28,988 shares of the company’s stock, valued at approximately $2,279,036.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://stocknewstimes.com/2017/08/17/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-hill-rom-holdings-hrc-share-price.html.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
